Optimizing Drug Trials through Multi-Modal AI

About

Optimizing Drug Trials through Multi-Modal AI

Raising

$257,511 / $2,000,000

Traction

– Addressing a Core Problem of Big Pharma with Multi-Modal AI

– Star Team of Scientists and Engineers

– Product V1 is Out and Used in Clinical Trials Today

Team

David Suendermann-Oeft

Founder & CEO; PhD EE, Munich; 160 Papers and Patents; Built Industrial Conversational AI Systems with 1B+ Interactions

David Pautler

Founder & CTO; PhD CS, Hawaii, Created World's First Open Voice Browser

Share Company

Think someone else might be interested in this company? Please fill out the form below and we will send an email to that person letting them know you suggested they take a look.


Learn More About The Company